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Abstract
Background—Congenital anomalies are a leading cause of infant morbidity and mortality. 
Studies suggest associations between environmental contaminants and some anomalies, although 
evidence is limited.
Methods—We used data from the California Center of the National Birth Defects Prevention 
Study and the Children's Health and Air Pollution Study to estimate the odds of 27 congenital 
heart defects with respect to quartiles of 7 ambient air pollutant and traffic exposures in California 
during the first two months of pregnancy, 1997–2006 (N=813 cases and N=828 controls).
Results—Particulate matter <10 microns (PM10) was associated with pulmonary valve stenosis 
(aOR4th Quartile=2.6; 95% CI: 1.2, 5.7) and perimembranous ventricular septal defects 
(aOR3rd Quartile=2.1; 95% CI: 1.1, 3.9) after adjusting for maternal race-ethnicity, education and 
multivitamin use. PM2.5 was associated with transposition of the great arteries 
(aOR3rd Quartile=2.6; 95% CI: 1.1, 6.5) and inversely associated with perimembranous ventricular 
septal defects (aOR4th Quartile=0.5; 95% CI: 0.2, 0.9). Secundum atrial septal defects were 
inversely associated with carbon monoxide (aOR4th Quartile=0.4; 95% CI: 0.2, 0.8) and PM2.5 
(aOR4th Quartile=0.5; 95% CI: 0.3, 0.8). Traffic density was associated with muscular ventricular 
septal defects (aOR4th Quartile=3.0, 95% CI: 1.2, 7.8) and perimembranous ventricular septal 
defects (aOR3rd Quartile =2.4; 95% CI: 1.3, 4.6), and inversely associated with transposition of the 
great arteries (aOR4th Quartile=0.3; 95% CI: 0.1, 0.8).
Conclusions—PM10 and traffic density may contribute to the occurrence of pulmonary valve 
stenosis and ventricular septal defects, respectively. The results were mixed for other pollutants 
and had little consistency with previous studies.
There are a large number of epidemiologic studies of associations between ambient air 
pollution exposure during pregnancy and adverse birth outcomes, including low birth 
weight, preterm birth and infant mortality.(1–3) In contrast, evidence examining air 
pollution exposures in relation to congenital anomalies is more limited. Congenital 
Corresponding Author: Amy M. Padula Stanford University 1265 Welsh Road Stanford, CA 94305 Ph: 650-724-1322 
ampadula@stanford.edu. 
HHS Public Access
Author manuscript
Paediatr Perinat Epidemiol. Author manuscript; available in PMC 2014 July 01.
Published in final edited form as:
Paediatr Perinat Epidemiol. 2013 July ; 27(4): 329–339. doi:10.1111/ppe.12055.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
anomalies are a leading cause of infant mortality and an important contributor to childhood 
and adult morbidity. Major structural congenital anomalies are diagnosed in 2–4% of births.
(4) Congenital heart defects are the leading cause of infant deaths due to congenital 
anomalies.(5–7) The etiologies are unknown for the majority of these defects.
Associations with carbon monoxide exposure have been suggested for selected congenital 
heart defects(8–10) though carbon monoxide may be acting as a surrogate for another causal 
agent such as traffic exposure. A recent meta-analysis of air pollution and 7,663 heart 
defects found associations between nitrogen dioxide, particulate matter <10 microns and 
sulfur dioxide with coarctation of the aorta, tetralogy of Fallot and atrial septal defects.(11) 
However, in general the results of previous studies have not been consistent in terms of the 
specific pollutants, the congenital heart defect affected subgroups, nor the direction or 
strength of associations,(11) possibly due to the heterogeneity of the origin of these defects. 
These associations with congenital heart defects are anatomically, clinically, and 
epidemiologically heterogeneous(12) and; therefore, should be analyzed in designated 
phenotypic groupings rather than as a single overall group.(12)To address the need for more 
data on possible associations between specific phenotypes of congenital heart defects and air 
pollution exposure, we used data from the California Center of the National Birth Defects 
Prevention Study(14) and the Children's Health and Air Pollution Study to investigate 
whether ambient air pollution and metrics of traffic exposure contributed to the risks of 
congenital heart defects in the San Joaquin Valley of California. The current study provides 
thorough case ascertainment and classification in a population-based case-control study and 
detailed exposure assessment in a region of the United States with known poor air quality. 
Previous results have been described regarding the association between air pollution and 
other structural birth defects including neural tube defects, orofacial clefts and gastroshisis 
in this study population.(15)
Methods
Study population
The California Center of the National Birth Defects Prevention Study (NBDPS) is a 
collaborative partnership between Stanford University and the California Birth Defects 
Monitoring Program in the Department of Public Health. The Center has been collecting 
data from women residing in eight counties (San Joaquin, Stanislaus, Merced, Madera, 
Fresno, Kings, Tulare, and Kern) in the San Joaquin Valley since 1997.
Data were collected using active ascertainment by the California Birth Defects Monitoring 
Program. Case information was obtained from hospital reports and medical records and 
entered into a standardized database for clinician review and classification. Cases in the 
current analysis included infants with 27 heart defect groupings following the classification 
proposed by Botto et al.(12) All cases were confirmed by clinical, surgical, or autopsy 
reports. Cases resulting from known single gene or chromosomal abnormalities or with 
identifiable syndromes were ineligible for the study, given their presumed distinct 
underlying etiology. The majority (~74%) of cases was isolated; i.e., no additional major 
unrelated congenital anomaly.
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Eligible cases included live births, stillbirths, and pregnancy terminations and were selected 
from the center's surveillance system based on strict eligibility criteria.(16) Controls 
included non-malformed live-born infants randomly selected from birth hospitals to 
represent the population from which the cases arose (approximately 150 per study year). 
Maternal interviews were conducted using a standardized, computer-based questionnaire, 
primarily by telephone, in English or Spanish, between six weeks and 24 months after the 
infant's estimated date of delivery. Estimated date of conception was derived by subtracting 
266 days from expected date of delivery. Expected date of delivery was based on self-report; 
if unknown, it was estimated from information in the medical record (<2% of participants).
Interviews were conducted with mothers of 70% of eligible cases and 69% of controls. 
Mothers reported a full residential history from one month before conception through 
delivery, including start and stop dates for each residence. Mothers with diabetes (Type 1 or 
2) prior to gestation were excluded (n=48). Addresses were geocoded using the Centrus 
Software (http://www.qmsoft.com/), which combines reference street networks from Tele 
Atlas (http://www.teleatlas.com/OurProducts/MapData/Dynamap/index.htm) and United 
States Postal Service data. Geocodes were available for 95% of cases and 93% of controls. 
The present analysis included 822 cases and 849 controls with an estimated delivery date 
between October 1, 1997 and December 31, 2006.
Exposure assessment
As part of the Children's Health and Air Pollution Study-San Joaquin Valley (CHAPSSJV), 
ambient air pollution measurements and traffic metrics were assigned to each of the 
geocoded residences reported by the study subjects during the first and second month of 
pregnancy. If there was more than one address during the period, the exposure assignments 
were calculated for the number of days at each residence. Exposure assignments were made 
if the geocodes were within the San Joaquin Valley and accounted for at least 75% of the 
first and second month of pregnancy. Daily 24-hour averages of the pollutants: carbon 
monoxide (CO), nitrogen oxide (NO), nitrogen dioxide (NO2), particulate matter less than 
10 μm (PM10), and PM less than 2.5 μm (PM2.5) and a daily daytime 8-hour maximum of 
ozone were then averaged over the first two months of pregnancy.
The principal repository for U.S. ambient air quality data is the U.S. Environmental 
Protection Agency's Air Quality System database (www.epa.gov/ttn/airs/airsaqs). The 
station-specific daily air quality data were spatially interpolated using inverse distance-
squared weighting. The data from one to four air quality measurement stations were 
included in each interpolation. When a residence was located within 5 km of one or more 
monitoring stations with valid observations, the interpolation was based solely on the nearby 
monitoring stations. Due to the regional nature of O3, NO2, PM10, and PM2.5 
concentrations, a maximum interpolation radius of 50 km was used. NO and CO were 
interpolated using a smaller maximum interpolation radius of 25 km since they are directly 
emitted pollutants with larger spatial gradients.
The data for gaseous pollutants were measured using Federal Reference Method (FRM) 
continuous monitors. Particulate matter data were primarily limited to those collected with 
FRM samplers and Federal Equivalent Method monitors. The national air monitoring 
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networks began measuring PM2.5 in 1999, therefore births with dates of conception prior to 
1999 were not part of the analyses of PM2.5.
Traffic density indicators were calculated to represent the traffic counts within a 300m 
radius of the early pregnancy residence. They were calculated from distance-decayed annual 
average daily traffic volumes(17) surrounding the geo-coded maternal residences. Roadway 
link-based traffic volumes were derived from Tele-Atlas/Geographic Data Technology 
traffic count data in 2005 using methodologies similar to those used in other health effects 
studies.(17) The Geographic Data Technology traffic count data were scaled to represent 
year 2003 traffic levels based on county average vehicle-miles-traveled growth rates 
(California Department of Transportation, 2004). Density plots were generated within a 
geographic information system using a linear decay function that approximates the fall-off 
of ambient concentrations with increasing distance away from roadways (i.e., decays to 
background within a given distance). Traffic density represents distance-decayed annual 
average daily traffic volume in both directions from all roads within the circular buffer. 
Traffic density is computed as if the wind directions were uniformly distributed around the 
compass and is symmetric on both sides of each roadway. The values are computed using 
the density function using a kernel with a 300 m search radius and 5 m grid resolution. In 
early analyses, we considered a radius of 150 m, though the estimates were not considerably 
different and previous literature focused on the 300 m radius.
Statistical analysis
Analyses were conducted to examine the association between the pollutants and traffic 
metrics. Each pollutant was examined by quartile as determined by the distribution in the 
controls. Traffic density was categorized into four groups: one for zero values and tertiles 
for the remaining non-zero values. Several potential covariates were also examined in 
relation to the exposures and the outcomes: maternal race/ethnicity (non-Hispanic white, 
U.S.-born Hispanic, foreign-born Hispanic, or other); education (less than high school, high 
school, more than high school); age (<20, 20–35, >35 years); parity (0, 1, >1); early 
pregnancy multi-vitamin use (one month prior to and/or first two months of pregnancy); 
active and/or passive smoking during one month before through two months after 
conception; period of delivery (1997–2000, 2001–2003, 2004–2006); and infant sex.
Multivariable logistic regression analyses were conducted to estimate adjusted odds ratios 
(aORs) and 95% confidence intervals (CI) reflecting the association between ambient air 
pollutants and traffic density and specific heart defect groupings.(12) Further, classification 
by isolated, multiple, or complex was not possible owing to sample size considerations. 
Multivariable analyses were performed adjusting for maternal race/ethnicity, education and 
early prenatal vitamin use. These covariates were selected a priori and based on causal 
assumptions derived from subject matter knowledge.(18) We considered the additional 
covariates and chose not to include them because they were colinear with other covariates 
(e.g., maternal age, parity), lacked indication as a confounder (e.g., infant sex), or had weak 
associations with the outcome and strong associations with the exposure (e.g., year of birth, 
season of birth).(19, 20) Stratum-specific odds ratios were compared to assess the role of 
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cigarette smoking as a potential modifier. Additionally, season of birth in this region is 
essentially a surrogate for many air pollutants rather than a confounder.
Analyses were conducted using SAS 9.3 (SAS Institute Inc., Cary, NC, 2011–2012). The 
study protocol was reviewed and approved by the institutional review boards of Stanford 
University and the California Department of Public Health.
Results
In the original 1675 geocoded residences during the first two months of pregnancy and 
within the boundaries of San Joaquin Valley counties, 99.8% were assigned a value for at 
least one exposure metric. The completeness for specific exposures was 76% for CO, 85% 
for NO, 98% for NO2, 97% for PM10, 98% for ozone and 91% for traffic density. Among 
infants born with dates of conception in 1999 or later, 97% were assigned an estimate for 
PM2.5 exposure. Cases had slightly higher (3%) completeness of exposure assignments for 
CO and NO compared to controls, but otherwise there was no difference.
The majority of mothers were Hispanic and had at least a high school education (Table 1). A 
quarter of the population was exposed to active or passive smoke. Mothers of cases were 
less likely to take multi-vitamins in early pregnancy and more likely to be multiparous.
The correlations of CO with NO (r=0.81), NO2 (r=0.73) and PM2.5 (r=0.84) were high, 
which reflects the common source of motor vehicles (Table 2). Ozone was negatively 
correlated with the traffic-related pollutants and traffic density was not correlated with any 
of the pollutants, as expected, due to the location of monitors away from sources (such as 
traffic) designed to capture regional air pollution.
Table 3 displays the results from the multivariable logistic regression models of each 
exposure and each heart defect group with at least 3 cases in each quartile of exposure and 
among participants with complete covariate data for the final model (N=1641). The crude 
results were not notably different from those shown. Partial anomalous pulmonary venous 
return, type A and type B interruption of the aortic arch, truncus arteriosus, Ebstein's 
anomaly, other ventricular septal defect, levo- transposition of the great arteries and other 
heart defects were not included because there were less than 3 cases per stratum. Our 
comments highlight results with odds ratios where the 95% confidence intervals did not 
include 1.0.
There was an inverse association between CO and risk of heterotaxia (aOR=0.2; 95% CI: 
0.1, 0.7) comparing the second to first quartile and secundum atrial septal defects (aOR=0.4; 
95% CI: 0.2, 0.8) comparing the highest to lowest quartile. No change in risk of congenital 
heart defects were associated with NO, NO2 or O3.
The odds of pulmonary valve stenosis was increased in the highest compared to the lowest 
quartile of PM10 exposure (aOR=2.6; 95% CI: 1.2, 5.7) and the increase of response by 
quartile was monotonic. The third quartile of PM10 was associated with perimembranous 
ventricular septal defects (aOR=2.1; 95% CI: 1.1, 3.9). The second and fourth quartiles had 
odds ratios >1, compared to the first quartile, though they were not statistically significant.
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An increased odds of d-transposition of the great arteries was associated with the 3rd quartile 
of PM2.5 (aOR=2.6, 95% CI: 1.1, 6.5). Similarly, the second and fourth quartiles had 
increased odds compared to the referent, though not statistically significant. We observed 
inverse associations between PM2.5 and perimembranous ventricular septal defects 
(aOR=0.5; 95% CI: 0.2, 0.9) and secundum atrial septal defects (aOR= 0.5; 95% CI: 0.3, 
0.8), comparing the highest to lowest quartile.
We observed positive associations between traffic density and ventricular septal defects, 
both muscular and perimembranous. The aOR comparing the highest quartile to the lowest 
for the muscular ventricular septal defects was 3.0 (95% CI: 1.2, 7.8). The second and third 
quartiles of traffic density were associated with perimembranous ventricular septal defects 
(aOR=2.4; 95% CI: 1.3, 4.6). The fourth quartile had increased odds as well, though lacked 
precision owing to small sample size. Traffic density was associated with secundum atrial 
septal defects comparing the second quartile to the 1st (aOR=2.4; 95% CI: 1.4, 4.0). The 
association was attenuated in the third and fourth quartiles. A decreased odds of d-
transposition of the great arteries was associated with the highest quartile of traffic density 
(aOR=0.3, 95% CI: 0.1, 0.8).
For defect groups with fewer than 3 cases in the referent group, we collapsed exposure 
designations by using a median cut-off for the individual pollutants and a cut-off of 33rd 
percentile of the non-zero values for traffic density. We found associations between 
pulmonary atresia and traffic density (aOR=3.9; 95% CI: 1.2, 12.2), and other atrial septal 
defects and PM10 (aOR=5.1; 95% CI: 1.5, 17.9) for above versus below the cut-off.
Observed patterns of associations did not differ substantially in the stratum-specific results 
among those exposed to active and passive smoke (data not shown). Given sample size 
considerations, the precision on such estimates was poor.
Comments
We explored the relation between 7 air pollution related exposure metrics and 27 congenital 
heart defect groups. There was sufficient sample size to estimate potential associations for 
19 defect groups. Although most pollutant-defect group comparisons did not provide clear 
evidence for associations, some statistically stable associations were notable. PM10 was 
associated with an increased odds of pulmonary valve stenosis and perimembranous 
ventricular septal defect, and PM2.5 with d-transposition of the great arteries. Traffic density 
was positively associated with perimembranous ventricular septal defects, muscular 
ventricular septal defects and secundum atrial septal defects. Inverse associations were 
observed of CO with heterotaxia and secundum atrial septal defects, PM2.5 with 
perimembranous ventricular septal defects and secundum atrial septal defects, and traffic 
with d-transposition of the great arteries.
The inconsistencies of the current results are not easily explained given the physical 
expectations from exposure science. These mixed results do not provide a clear conclusion 
about the association between air pollution and congenital heart defects. It is possible that 
either a) there are no associations between air pollution and congenital heart defects; b) our 
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data were not sufficient to detect and associations; c) there are confounding factors that were 
not measured that could clarify this relationship. In most cases, the exposure response was 
not monotonic as may be hypothesized. If there are vulnerable windows for certain heart 
defects that are narrower than our exposure period, we may have misclassified exposure. As 
with all birth defect studies, we are not able to account for early fetal loss that may bias the 
estimated odds ratios.
Two important considerations in the study of air pollution and congenital heart defects 
include rigorous case classification into specific defect groupings and precise spatiotemporal 
air pollution exposure assessment. The current study benefited from the rigorous case 
classification as part of the NBDPS. Secondly, the exposure assignments of the current study 
were able to incorporate residential history in early pregnancy, when the heart is formed. In 
a previous study of heart defects with 327 participants, 19% of cases and 23% of controls 
moved at least once between conception and delivery.(21) Previous studies of air pollution 
and congenital heart defects have relied on measurement of exposure at the birth residence 
rather than the residence early in pregnancy, thereby potentially misclassifying exposure for 
approximately 20% of their study population.(8, 9, 22–25) In some studies the exposure 
assignment relied on cruder spatial surrogates than residence such as zip code or a similar 
area measure.(10, 25) One study included traffic and meteorology in its spatiotemporal 
modeling of exposure.(24) However, none of these studies had considered residential history 
from early pregnancy and, therefore, could be subject to up to 20% of misclassification of 
exposure. NO and CO are particularly vulnerable to this misclassification due to the larger 
spatial gradients. The misclassification is likely less than 20% given most women do not 
move very far on average.
This is the first study to our knowledge to examine traffic density and congenital heart 
defects. Traffic density, which has been associated with other adverse birth outcomes such 
as low birth weight and preterm birth,(26–30) was associated with increased odds of three 
heart defects. An advantage of the traffic density parameter is that it accounts for the 
combined influence of all roadways and activity (for which data exist) near each residence 
location; however, wind direction was uniformly distributed.
The current study had a similar result to a study that found an association between PM10 and 
atrial septal defects, though our estimate was based on few cases comparing the above 
versus below median levels.(9) A recent meta-analysis of air pollution exposure and 
congenital anomalies reported increased odds of coarctation of the aorta and tetralogy of 
Fallot associated with NO2.(11) The current study shows estimates in the same direction 
across quartiles, though not statistically precise. Thus, our observations supplement the 
evidence reviewed by Vrijheid et al.(11)
There are also incongruities between the current study and previous studies. Two previous 
studies reported an association between ozone and pulmonary artery valve defects,(10, 25) 
and two reported an association between CO and ventricular septal defects.(8, 10) The 
current study did not find positive associations of CO or ozone with any heart defect 
grouping and found inverse associations of heterotaxia and secundum atrial septal defects. 
Pulmonary valve stenosis was associated with PM10 in our study, but CO in a previous study 
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in Europe.(8) The explanation for these discrepancies is unknown, but may be due to diverse 
exposure levels or mixtures, imprecision of estimates due to small sample size, measurement 
or misclassification error, or different case ascertainment and classification definitions.
For example, the discordant results of traffic density and PM2.5 were not expected and 
suggest that either or both may be subject to measurement or misclassification error. The 
pollutants are measured by monitors at the regional level and by design are located away 
from sources including heavy traffic. Traffic density captures the number of cars within 300 
meters in a given day; however, the traffic counts are not available on all streets nor on all 
days and are therefore estimated and prone to error. Particulate matter is a unique pollutant 
because it is measured based on its mass rather than its composition, which may be the 
critical factor in the etiology of birth defects. Although not common, measurement of the 
chemical composition of particulate matter is critical for health studies. Future analyses will 
pursue individual constituents such as polycyclic aromatic hydrocarbons, which may clarify 
these inconsistent results.
Our results contribute to a modest body of epidemiologic evidence regarding associations 
between air pollution exposure and congenital anomalies. The current study suggests that 
exposures to increased levels of PM10 and traffic density during the first two months of 
pregnancy may contribute to the occurrence of pulmonary valve stenosis and ventricular 
septal defects, respectively, in the San Joaquin Valley of California. Due to the 
inconsistencies within and across studies and the multiple comparisons which have been 
done by all studies, more research is necessary to elucidate the potential relations between 
air pollution and congenital heart defects.
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Table 1
Demographic characteristics as percent of subjects between 1997 and 2006 in 8 counties in the San Joaquin 
Valley of California (N=1671).
Percent of Cases (n=822) Percent of Controls (n=849)
Maternal education (years)
 <12 35 32
 12 29 27
 >12 36 40
 Missing <1 <1
Maternal race/ethnicity
 White 29 31
 Foreign-born Hispanic 34 29
 U.S.- born Hispanic 23 26
 Other 13 14
 Missing <1 <1
Multi-vitamin Usea
 Yes 62 65
 No 37 33
 Missing 1 2
Smokingb
 None 76 75
 Active only 6 8
 Passive only 11 10
 Active and passive 6 6
 Missing <1 <1
Maternal age (years)
 <25 40 46
 25–34 50 44
 ≥35 11 10
Infant sex
 Male 58 52
 Female 42 48
 Missing <1 0
Plurality
 Singletons 94 99
 Multiples 6 1
Parity
 0 32 39
 1 30 31
 2+ 37 32
Year of expected delivery date
 1997–2000 27 37
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Percent of Cases (n=822) Percent of Controls (n=849)
 2001–2003 36 33
 2004–2006 37 31
aAny folate-containing multi-vitamin use during one month before through two months after conception
bAny smoking during one month before through two months after conception
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Table 2
Pearson correlation coefficients of exposuresa among controls.
CO NO NO2 PM10 PM2.5 O3 8-hour maximum 300m Traffic Density
CO 1
NO 0.81 1
NO2 0.73 0.74 1
PM10 0.40 0.22 0.51 1
PM2.5 0.84 0.75 0.62 0.54 1
O3 8-hour maximum −0.57 −0.71 −0.35 0.17 −0.61 1
300m Traffic Density 0.01
p=0.76
0.03
p=0.40
0.11 −0.01
p=0.86
−0.004
p=0.92
0.02
p=0.61
1
p<0.05 except where noted
a
Pollutant levels are based on 24-hour average measurements (except where noted)
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